Cureos Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cureos Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cureos Science Today - Breaking & Trending Today

Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer

Published: May 16, 2024

Ipatasertib plus trastuzumab and pertuzumab as frontline maintenance therapy was effective and safe in PIK3CA-mutant, HER2-positive advanced breast cancer.

Source: onclive.com

Related Topics:

Comunidad Autonoma De CatalunaIsrael GeneralDaiichi Sankyo AstrazenecaMafalda OliveiraBreast Cancer CongressHebron University HospitalBreast Cancer GroupHebron Institute Of OncologyOncology Department Of The Breast Cancer GroupAyala PharmaceuticalsMedical Oncology DepartmentUniversity HospitalHebron InstituteZenith EpigeneticsCureos ScienceRelay Therapeutics